Europe is striving to be a prime location for testing and bringing new medicines to market, but experts say fragmentation, inconsistent interpretation of legislation, and lack of incentives stand in the way.

To strengthen its health R&D pipelines and prepare for the next health crisis, Europe needs to balance security concerns with greater industrial competitiveness

Will proposed EU pharmaceuticals package be flexible enough to accommodate new technologies and innovations?

COVID-19 caught Europe’s healthcare systems off-guard and drew attention away from other major health problems. But the lessons learned could lead to better healthcare.